Barbara Suzanne van der Meij

Dr. Barbara Suzanne van der Meij

Department of Nutrition, Dietetics and Lifestyle, School of Allied Health, HAN University of Applied Sciences, 6525 Nijmegen, The Netherlands
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
LGLynette De Groot
Lynette De Groot
GLGahee Lee
Gahee Lee
AAAntoinette Ackerie
Antoinette Ackerie
BMBarbara Suzanne van der Meij
Barbara Suzanne van der Meij
Background: A valid malnutrition screening tool (MST) is essential to provide timely nutrition support in ambulatory cancer care settings. The aim of this study is to investigate the validity of the Patient-Generated Subjective Global Assessment Short Form (PG-SGA SF) and the new Global Leadership Initiative on Malnutrition (GLIM) criteria as compared to the reference standard, the Patient-Generated Subjective Global Assessment (PG-SGA). Methods: Cross-sectional observational study including 246 adult ambulatory patients with cancer receiving in-chair intravenous treatment at a cancer care centre in Australia. Anthropometrics, handgrip strength and patient descriptive data were assessed. Nutritional risk was identified using MST and PG-SGA SF, nutritional status using PG-SGA and GLIM. Sensitivity (Se), specificity (Sp), positive and negative predictive values and kappa (k) were analysed. Associations between malnutrition and 1-year mortality were investigated by Cox survival analyses. Results: A PG-SGA SF cut-off score ≥5 had the highest agreement when compared with the PG-SGA (Se: 89%, Sp: 80%, k = 0.49, moderate agreement). Malnutrition risk (PG-SGA SF ≥ 5) was 31% vs. 24% (MST). For malnutrition according to GLIM, the Se was 76% and Sp was 73% (k = 0.32, fair agreement) when compared to PG-SGA. The addition of handgrip strength to PG-SGA SF or GLIM did not improve Se, Sp or agreement. Of 100 patients who provided feedback, 97% of patients found the PG-SGA SF questions easy to understand, and 81% reported that it did not take too long to complete. PG-SGA SF ≥ 5 and severe malnutrition by GLIM were associated with 1-year mortality risk. Conclusions: The PG-SGA SF and GLIM criteria are accurate, sensitive and specific malnutrition screening and assessment tools in the ambulatory cancer care setting. The addition of handgrip strength tests did not improve the recognition of malnutrition or mortality risk.

1 October 2010 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
BMBarbara Suzanne van der Meij
Barbara Suzanne van der Meij
JLJacqueline A. E. Langius
Jacqueline A. E. Langius
ESEgbert F. Smit
Egbert F. Smit
MSMarieke D. Spreeuwenberg
Marieke D. Spreeuwenberg
BBB. Mary E. von Blomberg
B. Mary E. von Blomberg
PLPaul A. M. van Leeuwen
Paul A. M. van Leeuwen
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), (n-3) fatty acids from fish oil, have immune-modulating effects and may improve nutrition

11 January 2012 in European Journal of Clinical Nutrition
Verified
Journal Article
Open access
BMBarbara Suzanne van der Meij
Barbara Suzanne van der Meij
JLJ A E Langius
J A E Langius
MSM D Spreeuwenberg
M D Spreeuwenberg
SSS M Slootmaker
S M Slootmaker
MPM A Paul
M A Paul
PLP A M van Leeuwen
P A M van Leeuwen
Background/Objectives: Subjects/Methods: Results: Conclusion:

26 July 2017 in Journal of the American Geriatrics Society
Verified
Journal Article
Open access
PDF file
BMBarbara Suzanne van der Meij
Barbara Suzanne van der Meij
HWHanneke A.H. Wijnhoven
Hanneke A.H. Wijnhoven
JLJung S. Lee
Jung S. Lee
DHDenise K. Houston
Denise K. Houston
THTrisha Hue
Trisha Hue
MVMarjolein Visser
Marjolein Visser
Background/objectives: Poor appetite in older adults leads to sub‐optimal food intake and increases the risk of undernutrition. The impact of poor appetite on food intake in older adults is unknown. The aim of this study was to examine the differences in food intake among older community‐dwelling adults with different reported appetite levels. Design: Cross‐sectional analysis of data from a longitudinal prospective study. Setting: Health, aging, and body composition study performed in the USA . Participants: 2,597 community‐dwelling adults aged 70–79. Measurements: A semi‐quantitative, interviewer‐administered, 108‐item food frequency questionnaire designed to estimate dietary intake. Poor appetite was defined as the report of a moderate, poor, or very poor appetite in the past month and was compared with good or very good appetite. Results: The mean age of the study sample was 74.5 ± 2.8 years; 48.2% were men, 37.7% were black, and 21.8% reported a poor appetite. After adjustment for total energy intake and potential confounders (including biting/chewing problems), participants with a poor appetite had a significantly lower consumption of protein and dietary fiber, solid foods, protein rich foods, whole grains, fruits, and vegetables, but a higher consumption of dairy foods, fats, oils, sweets, and sodas compared to participants with very good appetite. In addition, they were less likely to report consumption of significant larger portion sizes. Conclusion: Older adults reporting a poor appetite showed a different dietary intake pattern compared to those with (very) good appetite. Better understanding of the specific dietary intake pattern related to a poor appetite in older adults can be used for nutrition interventions to enhance food intake, diet variety, and diet quality.

1 February 2008 in Clinical Nutrition
Verified
Journal Article
Closed access
PWPeter J.M. Weijs
Peter J.M. Weijs
HKHinke M. Kruizenga
Hinke M. Kruizenga
ADAimee E. van Dijk
Aimee E. van Dijk
BMBarbara Suzanne van der Meij
Barbara Suzanne van der Meij
JLJacqueline A.E. Langius
Jacqueline A.E. Langius
MSMarian A.E. van Bokhorst-De van der Schueren
Marian A.E. van Bokhorst-De van der Schueren

16 November 2012 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
BMBarbara Suzanne van der Meij
Barbara Suzanne van der Meij
CSColine P. Schoonbeek
Coline P. Schoonbeek
ESEgbert F. Smit
Egbert F. Smit
MMMaurizio Muscaritoli
Maurizio Muscaritoli
PLPaul A. M. van Leeuwen
Paul A. M. van Leeuwen
JLJacqueline A. E. Langius
Jacqueline A. E. Langius
Despite the development of consensus-based frameworks to define cancer cachexia, the validity and usefulness of these frameworks are relatively unknown. The aim of the present study was to study the presence of pre-cachexia and cachexia in patients with stage III non-small-cell lung carcinoma (NSCLC) by using a cancer-specific framework and a general framework for cachexia, and to explore the prognostic value of pre-cachexia and cachexia. In forty patients at diagnosis of stage III NSCLC, weight loss, fat-free mass, handgrip strength, anorexia and serum biochemistry, assessed before the first chemotherapy, were used to define ‘cancer cachexia’ or ‘cachexia’. The cancer-specific framework also classified for pre-cachexia and refractory cachexia. Additionally, quality of life was assessed by the European Organisation for Research and Treatment of Cancer – Quality of Life Questionnaire C30. Groups were compared using independent t tests, ANOVA, Kaplan–Meier and Cox survival analyses. Based on the cancer-specific framework, pre-cachexia was present in nine patients (23 %) and cancer cachexia was present in seven patients (18 %). Cancer cachexia was associated with a reduced quality of life (P= 0·03) and shorter survival (hazard ratio (HR) = 2·9; P= 0·04). When using the general framework, cachexia was present in eleven patients (28 %), and was associated with a reduced quality of life (P= 0·08) and shorter survival (HR = 4·4; P= 0·001). In conclusion, pre-cachexia and cachexia are prevalent in this small population of patients at diagnosis of stage III NSCLC. For both frameworks, cachexia appears to be associated with a reduced quality of life and shorter survival. Further studies are warranted to more extensively explore the validity and prognostic value of these new frameworks in cancer patients.